Effect of tannin extract against Pseudomonas aeruginosa producing metallo beta-lactamase

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 2, 2012, Pages 231-236

  Ghafourian, S ^a,b   Mohebi, R ^a   Sekawi, Z ^b   Raftari, M ^b   Neela, V ^b   Ghafourian, E ^a   Aboualigalehdari, E ^a   Rahbar, M ^c   Sadeghifard, Nourkhoda ^a  

^a ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c Iranian Reference Health Laboratory   (Iran)

Author keywords

Pseudomonas aeruginosa; Tannin; Urinary tract infection

Indexed keywords

EDETIC ACID; IMIPENEM; METALLO BETA LACTAMASE; TANNIN;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLAIMP GENE; BLAVIM GENE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; GENOTYPE; HUMAN; IC 50; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA; URINARY TRACT INFECTION;

ANIMALS; BETA-LACTAMASES; CERCOPITHECUS AETHIOPS; HUMANS; IMIPENEM; PSEUDOMONAS AERUGINOSA; TANNINS; URINARY TRACT INFECTIONS; VERO CELLS;

EID: 84865001244     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Niederman MS. Appropriate use of antimicrobial agents: Challenges and strategies for improvement. Crit Care Med 2003; 31:608-16. (Pubitemid 36232962)
2. Ambler RP. The structure of β-lactamases. Phil.Trans R Soc Lond B Biol Sci 1989; 289:321-31.
3. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002; 8:321-31. (Pubitemid 34993804)
4. Finch R. Antibiotic resistance from pathogen to disease surveillance. Clin Microbiol Infect 2002; 8:317-20. (Pubitemid 34993803)
5. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18:306-25.
6. Pournaras S, Woodford N, Palepou MFI, Babini GS, Douboyas, Livermore DM. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol 2000; 38:1290-92. (Pubitemid 30140608)
7. Crespo MP, Woodford N, Sinclair A, et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care centre in Cali, Colombia. J.Clin Microbiol 2004; 42:5094-101. (Pubitemid 39506216)
8. Lee K, Kim YA, Park YJ, et al. Increasing prevalence of imipenem-resistant Pseudomonas aeruginosa and molecular typing of metallo-beta-lactamase producers in a Korean hospital. Microb Drug Resist 2005; 11:355-9.
9. Babay HAH. Antimicrobial Resistance among Clinical Isolates of Pseudomonas aeroginosa from patient in teaching hospital, Riadeh, Saudi Arabia, 2001-2005. Jpn J Infect Dis 2007; 60:123-6.
10. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002; 40:3798-801.
11. Docquier JD, Riccio ML, Mugnaioli C, et al. IMP-12, a new pRlasmid-encoded metallo-beta-lactamase from a Pseudomonas putida clinical isolate. Antimicrob Agents Chemother 2003; 47:1522e1528.
12. Shoemaker M, Hamilton B, Dairkee SH, Cohen I, Campbell MJ. In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res 2005; 19:49-651.
13. Philip D, Kaleena PK, Valivittan K. In vitro cytotoxicity and anticancer activity of Sanseviera roxburghiana. Int J Curr Pharmac Res 2011; 3(3):71-73.
14. Laupland KB, Parkins MD, Church DL, et al. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance ofnmetallo-beta-lactamase (MBL)-producing strains. J Infect Dis 2005; 192:1606-12. (Pubitemid 41504696)
15. Yazdi HR, Nejad JB, Peerayeh SN, Mostafaee M. Prevalence and detection of metallo - lactamase (MBL)-producing Pseudomonas aeruginosa strains from clinical isolates in Iran. Ann Microbiol 2007; 57(2):293-95. (Pubitemid 47112679)